1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. Massachusetts >
  6. CervoMed Acquires EIP Pharma

M&A Deal Summary

CervoMed Acquires EIP Pharma

On March 30, 2023, CervoMed acquired life science company EIP Pharma

Acquisition Highlights
  • This is CervoMed’s 2nd transaction in the Life Science sector.
  • This is CervoMed’s 2nd transaction in the United States.
  • This is CervoMed’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2023-03-30
Target EIP Pharma
Sector Life Science
Buyer(s) CervoMed
Deal Type Merger
Advisor(s) Mintz Levin Cohn Ferris Glovsky and Popeo (Legal)

Target

EIP Pharma

Boston, Massachusetts, United States
EIP Pharma is a clinical-stage biotechnology company advancing CNS-focused therapeutics to benefit patients with a range of debilitating neurodegenerative diseases. EIP Pharma was founded in 2014 and is based in Boston, Massachusetts.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

CervoMed

Boston, Massachusetts, United States
Category Company
Founded 2001
Sector Life Science
Employees15
DESCRIPTION

CervoMed is a biotechnology company develops new treatments to improve the body’s ability to bring oxygen to the areas where it is needed most, offering new hope for the treatment of life-threatening medical conditions. CervoMed was founded in 2001 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Merger M&A Deals 2 of 2
State: Massachusetts M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2023 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-08 RestorGenex

Buffalo Grove, Illinois, United States

RestorGenex Corp. is a biopharmaceutical company with an initial focus on dermatology, ocular diseases and women's health. RestorGenex is based in Buffalo Grove, Illinois.

Buy -
Mergr

Solution for

Product

Company

Legal